Merit Medical Systems (MMSI) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

MMSI Stock Forecast


Merit Medical Systems (MMSI) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $106.33, with a high of $110.00 and a low of $103.00. This represents a 12.21% increase from the last price of $94.76.

$70 $78 $86 $94 $102 $110 High: $110 Avg: $106.33 Low: $103 Last Closed Price: $94.76

MMSI Stock Rating


Merit Medical Systems stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (91.67%), 1 Hold (8.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 12 0 1 11 Strong Sell Sell Hold Buy Strong Buy

MMSI Price Target Upside V Benchmarks


TypeNameUpside
StockMerit Medical Systems12.21%
SectorHealthcare Stocks 30.37%
IndustryMedical Instruments & Supplies Stocks25.78%

Price Target Trends


1M3M12M
# Anlaysts3313
Avg Price Target$106.33$106.33$103.54
Last Closing Price$94.76$94.76$94.76
Upside/Downside12.21%12.21%9.27%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25551--11
Mar, 25451--10
Feb, 25451--10
Jan, 25451--10
Dec, 24552--12
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 25, 2025Michael PetuskyBarrington$103.00$93.869.74%8.70%
Oct 15, 2024David RescottRobert W. Baird$107.00$95.5212.02%12.92%
Sep 16, 2024Mike MatsonNeedham$105.00$96.169.19%10.81%
Sep 16, 2024Larry BiegelsenWells Fargo$103.00$96.167.11%8.70%
Sep 16, 2024Craig BijouBank of America Securities$103.00$96.167.11%8.70%
Sep 09, 2024Jason BednarPiper Sandler$110.00$96.5813.90%16.08%
Aug 05, 2024Craig BijouBank of America Securities$92.00$87.445.22%-2.91%
Aug 02, 2024Jason BednarPiper Sandler$100.00$86.8615.13%5.53%
Jul 02, 2024John YoungCanaccord Genuity$125.00$85.6445.96%31.91%
Jun 13, 2024Larry BiegelsenWells Fargo$85.00$83.252.10%-10.30%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Apr 25, 2025Wells FargoOverweightOverweighthold
Dec 11, 2024Wells FargoBuyOverweightupgrade
Oct 18, 2024Sandler O'NeillUnderperformUnderperformhold
Sep 17, 2024Canaccord GenuityBuyBuyhold
Sep 16, 2024Wells FargoBuyBuyhold
Sep 16, 2024NeedhamBuyBuyhold
Sep 16, 2024Wells FargoEqual-WeightEqual-Weighthold
Sep 16, 2024Bank of America SecuritiesNeutralNeutralhold
Sep 09, 2024Piper SandlerOverweightOverweighthold
Aug 28, 2024NeedhamUnderperformUnderperformhold

Financial Forecast


EPS Forecast

$-1 $0 $1 $2 $3 $4 $5 $6 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.18$0.86$1.31$1.64-----
Avg Forecast$1.56$2.17$2.58$2.97$3.36$3.74$4.20$4.58$5.02
High Forecast$1.59$2.21$2.60$2.99$3.38$3.81$4.51$4.63$5.07
Low Forecast$1.54$2.15$2.55$2.95$3.35$3.69$3.79$4.50$4.92
Surprise %-111.54%-60.37%-49.22%-44.78%-----

Revenue Forecast

$900M $1B $1B $1B $2B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$963.88M$1.07B$1.15B$1.26B$1.30B----
Avg Forecast$956.32M$1.07B$1.15B$1.25B$1.35B$1.48B$1.57B$1.71B$1.83B
High Forecast$970.54M$1.08B$1.16B$1.26B$1.36B$1.49B$1.57B$1.71B$1.85B
Low Forecast$947.86M$1.06B$1.14B$1.24B$1.33B$1.46B$1.57B$1.70B$1.81B
Surprise %0.79%0.71%0.29%0.32%-3.78%----

Net Income Forecast

$-50M $20M $90M $160M $230M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-9.84M$48.45M$74.52M$94.41M-----
Avg Forecast$90.82M$32.76M$45.70M$94.41M$196.43M$218.71M$242.24M$266.43M$292.75M
High Forecast$92.57M$39.32M$54.84M$113.29M$197.31M$222.22M$263.38M$270.30M$295.86M
Low Forecast$89.77M$26.21M$36.56M$75.53M$195.56M$215.20M$221.11M$262.56M$287.39M
Surprise %-110.84%47.89%63.05%------

MMSI Forecast FAQ


Is Merit Medical Systems stock a buy?

Merit Medical Systems stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Merit Medical Systems is a favorable investment for most analysts.

What is Merit Medical Systems's price target?

Merit Medical Systems's price target, set by 12 Wall Street analysts, averages $106.33 over the next 12 months. The price target range spans from $103 at the low end to $110 at the high end, suggesting a potential 12.21% change from the previous closing price of $94.76.

How does Merit Medical Systems stock forecast compare to its benchmarks?

Merit Medical Systems's stock forecast shows a 12.21% upside, underperforming the average forecast for the healthcare stocks sector (30.37%) and underperforming the medical instruments & supplies stocks industry (25.78%).

What is the breakdown of analyst ratings for Merit Medical Systems over the past three months?

  • April 2025: 45.45% Strong Buy, 45.45% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 40.00% Strong Buy, 50.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 40.00% Strong Buy, 50.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.

What is Merit Medical Systems’s EPS forecast?

Merit Medical Systems's average annual EPS forecast for its fiscal year ending in December 2025 is $3.74, marking a 0% decrease from the reported $0 in 2024. Estimates for the following years are $4.2 in 2026, $4.58 in 2027, and $5.02 in 2028.

What is Merit Medical Systems’s revenue forecast?

Merit Medical Systems's average annual revenue forecast for its fiscal year ending in December 2025 is $1.48B, reflecting a 13.43% increase from the reported $1.3B in 2024. The forecast for 2026 is $1.57B, followed by $1.71B for 2027, and $1.83B for 2028.

What is Merit Medical Systems’s net income forecast?

Merit Medical Systems's net income forecast for the fiscal year ending in December 2025 stands at $218.71M, representing a 0% decrease from the reported $0 in 2024. Projections indicate $242.24M in 2026, $266.43M in 2027, and $292.75M in 2028.